Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jun 21 2019

Full Issue

Legislation Would Ensure Preference Given To American Companies For Pentagon Research Funding

A bioscience company's decision to find a partner in China prompted the introduction of the measure. The legislation is the most recent example of the Trump administration and members of Congress taking a more aggressive role to counter the economic and national-security risks posed by China’s rise as a biotech power. Other news from Capitol Hill deals with abortion, black lung, and the 9/11 victims fund.

The Wall Street Journal: Congress Targets China’s Biotech Ambitions

Pentagon funding helped San Francisco startup Twist Bioscience Corp. get off the ground. Then the maker of synthetic DNA got a partner in China, where it now plans to expand manufacturing and set up a subsidiary with the money from its recent initial public offering. In effect, the Defense Department’s nearly $5 million in funding for Twist served as a small boost to China’s rising biotech industry, which will benefit from the firm’s presence and the manufacturing jobs it creates. (O'Keefe, 6/20)

The Hill: Democrat, Trump Nominee Have Fiery Exchange Over Abortion Rights For Rape Victims

President Trump's nominee to be the U.S. Representative to the United Nations Office in Geneva sparred with the top Democrat on the Senate Foreign Relations Committee on Thursday over whether rape victims should be allowed to have abortions. "Should victims of sexual violence be able to terminate the pregnancy where legal?," the committee's ranking member, Sen. Bob Menendez (D-N.J.), asked nominee Andrew Bremberg, currently the director of the Domestic Policy Council for the White House. (Siegel, 6/20)

NPR: Regulators Resist Call For Action In Response To Black Lung Epidemic

The nation's top coal mine safety regulator told members of Congress Thursday that existing safety regulations are sufficient to protect miners from toxic dust, despite calls for change amid an epidemic of advanced black lung disease among coal miners in Appalachia. Assistant Secretary of Labor David Zatezalo, testifying before the House Workforce Protections Subcommittee, said sampling from coal mines shows a 99% compliance rate with rules designed to limit workers' exposure to silica, the dust blamed for the disease outbreak. (Berkes and Jingnan, 6/20)

The Washington Post: Luis Alvarez, 9/11 Responder Who Fought For Victim Fund With Jon Stewart, Moves To Hospice

In what he indicated was his final interview, Luis Alvarez’s message was simple: It’s time for the government to make things right. The retired New York Police Department detective and Ground Zero responder implored members of Congress last week to reauthorize funding for people injured or sickened as a result of the 9/11 attacks. His heart-wrenching testimony drew national attention, one day before what would have been his 69th chemotherapy session to treat Stage 4 cancer. He was diagnosed 16 years after he rushed to Ground Zero after the twin towers collapsed. (Brice-Saddler, 6/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF